Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2005-03-03
2009-10-20
Wilson, James O (Department: 1624)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C548S400000
Reexamination Certificate
active
07605176
ABSTRACT:
Compounds of formula Iwherein the groups and residues A, B, b, X, Y, Z, R1, R2, R3, R5aand R5bhave the meanings given in claim1. The invention further relates to pharmaceutical compositions containing at least one amide according to the invention. As a result of their MCH-receptor antagonistic activity the pharmaceutical compositions according to the invention are suitable for the treatment of metabolic disorders and/or eating disorders, particularly obesity, bulimia, anorexia, hyperphagia, and diabetes.
REFERENCES:
patent: 2004/0063686 (2004-04-01), Johnson et al.
patent: 2004/0077628 (2004-04-01), Ishihara et al.
patent: 2005/0059651 (2005-03-01), Armstrong et al.
patent: 1 283 199 (2003-02-01), None
patent: 1 285 651 (2003-02-01), None
patent: 1 539 667 (2005-11-01), None
patent: WO 98/38156 (1998-09-01), None
patent: WO 01/21577 (2001-03-01), None
patent: WO 02/10146 (2002-02-01), None
patent: WO 03/033476 (2003-04-01), None
patent: WO 2004/024702 (2004-03-01), None
patent: WO 2004/039764 (2005-05-01), None
patent: WO 2005/063239 (2005-07-01), None
Hervieu, G. Expert Opinion in Therapeutic Targets, 2003, 7(4), 495-511.
Crow, S. Expert Opinion in Investigational Drugs, 1997, 6(4), 427-36.
Pennini, R. et al; “Condensation of n-alkyl-o-phenylenediamine With Ethyl Benzoylacetate”, Farmaco, Edizione, Scientifica, Bd. 31 ,Nr. 2, 1976, pp. 120-125, XP002334423.
Lehmann-Lintz Thorsten
Lotz Ralf R. H.
Lustenberger Philipp
Mueller Stephan Georg
Roth Gerald Juergen
Boehringer Ingelheim International GmbH
Devlin Mary-Ellen M.
Jarrell Noble
Morris Michael P.
Wilson James O
LandOfFree
β-ketoamide compounds with MCH antagonistic activity does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with β-ketoamide compounds with MCH antagonistic activity, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and β-ketoamide compounds with MCH antagonistic activity will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4131886